Recent studies showed that CYP6AY1 metabolized imidacloprid more efficiently and CYP6ER1 gene could be up-regulated by imidacloprid at a higher level and metabolic imidacloprid resistance in BPH relies on multiple P450 enzymes16,21. Here, CYP2B6 is linked to benign prostatic hyperplasia.